MENUNews Archive
Date: 04/12/2023
Barriers to genetic testing for patients with cancer may vary based on demographics and other personal factors, a pilot project associated with a large clinical trial found. In a University of Michigan study, women, for instance, were more likely to report worries about the implications of their test results for family members and how their results could affect their health and life insurance.
Date: 04/11/2023
After years in the shadow of more common cancers, there’s new light for patients with thyroid cancer. Increased use of neck ultrasounds has driven up the number of people globally who are diagnosed with thyroid cancer, which has brought new attention to the disease. It’s now the ninth most common cancer worldwide.
Date: 04/11/2023
Rogel Cancer Center faculty and trainees will lead over two dozen presentations, posters and moderated sessions at the American Association for Cancer Research annual meeting. This year’s meeting will be held in-person. View the schedule of presentations.
Date: 04/04/2023
To understand the molecular processes that influence how cancer cells pass through the blood-brain barrier, Dr. Sofia Merajver and colleagues used two microfluidic chips that mapped cancer cell migration to the brain and looked at what was happening in the blood-brain niche.
Date: 04/03/2023
The Rogel Cancer Center is partnering with the Institute for Healthcare Policy and Innovation to help teams translate research into policy. The collaboration offers a cancer-specific opportunity under IHPI’s Policy Sprints program, which launched in 2018 to provide policymakers and stakeholders with timely and rigorous evidence to inform health policy or practice at the local, state, national, or global levels.
Date: 03/31/2023
The University of Michigan Rogel Cancer Center has been re-accredited by the Commission on Cancer, a quality program of the American College of Surgeons. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care. The Rogel Cancer Center was first accredited by CoC in 1932, making it one of the first cancer programs to receive accreditation.
Date: 03/29/2023
Using artificial intelligence, researchers have discovered how to screen for genetic mutations in cancerous brain tumors in under 90 seconds — and possibly streamline the diagnosis and treatment of gliomas, a study suggests.
Date: 03/27/2023
Maria G. Castro, Ph.D., R. C. Schneider Collegiate Professor of Neurosurgery and professor of cell and developmental biology at the University of Michigan, was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
Date: 02/27/2023
Paul Swiecicki, M.D., has been named the inaugural associate medical director for the Oncology Clinical Trials Support Unit at the Rogel Cancer Center. The appointment was effective Jan. 1, 2023.
Date: 02/27/2023
Diversity, equity, inclusion and justice are a crucial part of the Rogel Cancer Center’s mission, from Community Outreach and Engagement programs addressing health care disparities to hiring processes and leadership development. Now, diversity is a new requirement from the National Cancer Institute for its Cancer Center Support Grants, a chapter they refer to as the Plan to Enhance Diversity. In submitting the CCSG renewal last year, Rogel leadership provided a detailed outline of how we will support a diverse workforce.